Show Summary Details
Page of

Advocacy, campaigning, lobbying: Good or bad? 

Advocacy, campaigning, lobbying: Good or bad?
Advocacy, campaigning, lobbying: Good or bad?

Mohammad Wasay

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 April 2021

Advocacy is a strong tool to bring about changes and improvements in society. Healthcare advocacy is increasing globally. Objectives of advocacy, formulation of message, and proper analysis of conflicts of opinion and interests are mandatory for designing an advocacy campaign. Both short- and long-term outcomes should be discussed and planned before starting a project. The methodology may be extremely important in defining the outcome of a project. Good or bad advocacy is dependent upon objectives and outcomes of a project. There could be multiple stakeholders relating to an advocacy campaign. Collaboration with stakeholders is a must for any successful campaign but roles should be well-thought out and discussed. This interaction and collaboration is called lobbying. It is an integral part and important component of advocacy. The dangers of advocacy include increased intensity of conflicts and counter-advocacy.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.